BioSpace News Archive

Pharming Group N.V. presents its (unaudited) interim financial report for the first quarter ended 31 March 2019.

Probiodrug AG announced today its first quarter business update for the period ending March 31, 2019.

FDA Cleared and CE Marked, Telescope Enters Global Market with Design Innovations to Enable Smooth Delivery of Coronary Stents and Balloons

Primary analysis of L-MIND trial of tafasitamab (MOR208) plus lenalidomide in relapsed or refractory (r/r) DLBCL confirms overall strong data reported previously from this trial

Agios Pharmaceuticals, headquartered in Cambridge, Mass., announced that its Tibsovo (ivosidenib) hit its primary endpoint in the Phase III ClarIDHy trial in patients with cholangiocarcinoma with an isocitrate dehydrogenase 1 (IDH1) mutation.

The Radiology Imaging Associates, PC (RIA) Interventional Radiology (IR) Physician Section will treat patients in the new RIA Interventional Suite located at the Centrum in Denver Tech Center [16-May-2019] DENVER , May 16, 2019 /PRNewswire/ -- The RIA Endovascular Clinic has opened the first office-based Interventional Suite in metro Denver , located inside the Clini

Guthrie Being Honored as a Healthcare Technology Pioneer

At the 2019 Amgen Tour of California, the Rally UHC Cycling team will once again ride six “Inspired Bikes” to benefit the UnitedHealthcare Children’s Foundation.

Partners in five countries will discover and develop monoclonal antibodies to treat critical illness from snake venom, which harms nearly 3 million people each year

We are pleased to launch our new Fusion Equipment Package from Forest Dental.